Additionally, in-vitro studies showed that the pretreatment of both CS-SeNPs and Na2SeO3 significantly inhibited LPS-induced endothelial dysfunction, inflammation and activation of NF-κB signaling pathway in human EC line EA.hy926. The gene discussed is NFKB1; the disease is endothelial dysfunction.